Clik here to view.
経口薬OTEZLA®（アプレミラスト）が中等度から重度の尋常性乾癬患者の治療薬として米食品医薬品局の承認を取得
米ニュージャージー州サミット （ビジネスワイヤ） — セルジーン・コーポレーション（NASDAQ:...
View ArticleClik here to view.
美国食品药品管理局核准Oral OTEZLA® (apremilast)用于治疗中重度斑块状银屑病患者
新泽西州萨米特 (美国商业资讯) — Celgene Corporation (NASDAQ: CELG)今天宣布，美国食品药品管理局(FDA)已核准该公司的磷酸二酯酶4 (PDE4) 选择性抑制剂口服制剂OTEZLA®...
View ArticleClik here to view.
22nd Century Group与FDA会面，以推动潜在减害卷烟的开发
纽约州克拉伦斯 (美国商业资讯) –22nd Century Group, Inc. (NYSE MKT:XXII)今天宣布，美国食品药品管理局(“FDA”)烟草产品中心(“CTP”)将于2014年11月12日与该公司会面，讨论该公司潜在减害烟草产品的进一步开发，该产品的编码名称是BRAND B...
View ArticleClik here to view.
PharmaEngine and Merrimack Amend MM-398 License Agreement
TAIPEI, Taiwan PharmaEngine, Inc. (TWO: 4162), announced today that the company has signed an Amendment to its License Agreement of MM-398 (aka PEP02, nanoliposomal irinotecan injection, nal-IRI)...
View ArticleClik here to view.
22ndセンチュリー・グループ、リスク低減紙巻たばこ候補の開発促進でFDAとの会議が承認される
米ニューヨーク州クラレンス （ビジネスワイヤ） — 22ndセンチュリー・グループ（NYSE...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA...
BOTHELL, Wash. & OSAKA, Japan Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received...
View ArticleClik here to view.
ReproCELL Launches Cell Innovation Partners, L.P. with Shinsei Bank, Limited
YOKOHAMA, Japan ReproCELL (JASDAQ:4978) announced that it has commenced operation of “Cell Innovation Partners, L.P.” (hereafter “the Fund”) at the size of about USD 8.0 million, as of September 26,...
View ArticleClik here to view.
NEC Corporation to Market SomaLogic’s SOMAscan™ Assay in Japan
BOULDER, Colo. SomaLogic, Inc. and NEC Corporation (TYO: 6701) announced today an agreement that gives NEC exclusive marketing rights in Japan for SomaLogic’s SOMAscan™ assay, which is built on...
View ArticleClik here to view.
BioJapan 2014 World Business Forum 出展企業プロフィール
横浜 （ビジネスワイヤ） – BioJapan 2014 World Business Forumが、2014年10月15日（水）～ 17（金）に、パシフィコ横浜（横浜市西区）で開催されます。 ビジネスワイヤはBioJapan...
View ArticleClik here to view.
BioJapan 2014 World Business Forum Exhibitor Profiles
YOKOHAMA, Japan BioJapan 2014 World Business Forum takes place October 15 – 17 at the PACIFICO YOKOHAMA in Yokohama, Japan. Business Wire is the official media partner for the BioJapan 2014....
View ArticleClik here to view.
‘China (Zhangjiajie) Giant Salamander’ Public Exhibition (Longyan Station)...
ZHANGJIAJIE, China The public exhibition (Longyan Station) of the ‘China (Zhangjiajie) Giant Salamander’ was held in Sunrise City Mall, Longyan, Fujian Province, China from 19 September to 21...
View ArticleClik here to view.
Tokyo Electron Launches its Open Innovation Stem Cell Technology Centre (STC)...
TOKYO Tokyo Electron Limited (TEL) opened, through its European subsidiary Tokyo Electron Europe Limited (TEE), the company’s open innovation centre at Stevenage Bioscience Catalyst (SBC) in the...
View ArticleClik here to view.
BIO Congratulates India’s New Prime Minister on First Official Visit to the...
WASHINGTON The following statement may be attributed to BIO President and CEO Jim Greenwood: “On behalf of the Biotechnology Industry Organization, I congratulate India’s new Prime Minister,...
View ArticleClik here to view.
【 BioJapan 】 － アジア最大級のバイオ総合展 －世界のバイオ企業が日本に熱視線！ビッグファーマ・ベンチャー・アカデミアが創る新バイオビジネス
東京 （ビジネスワイヤ） — 来る2014年10月15日（水）～17日（金）の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2014 – World Business Forum – を開催します。 BioJapan...
View ArticleClik here to view.
PeptiDream Announces Extension and Advancement of a Peptide Discovery Program
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”) (Tokyo:4587), announced today that one of the discovery programs initiated under the strategic alliance with...
View ArticleClik here to view.
EDPバイオテックが大腸がん早期発見に資するインビトロ診断ツールColoMarkerのCEマーク認証取得と欧州での商業化計画を発表
米テネシー州ノックスビル （ビジネスワイヤ） —...
View ArticleClik here to view.
エリテックが急性リンパ芽球性白血病を対象とするGRASPA®の試験で第III相の優れて良好な結果を発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
Nitto: New Anti-Fibrosis Drug With Molecular Targeting DDS Starts Phase-1B...
OSAKA, Japan Nitto Denko Corporation (Nitto) (TOKYO:6988)(ISIN:JP3684000007) announces the initiation of a phase-1b clinical study in the US started on September 2014, to administer a new...
View ArticleClik here to view.
DNA Sequencing HPV Testing and Pap Smears Necessary for Optimum Patient Care,...
MILFORD, Conn. Sin Hang Lee, M.D., a Milford (Conn.) Hospital pathologist and lead author of “From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice,” a...
View ArticleClik here to view.
PrIME Biologics Announces SGD16M in Equity Funding Led by Xeraya Capital
SINGAPORE PrIME Biologics Private Limited today announced investments from Xeraya Capital Labuan Ltd via its affiliate, Pulau Manukan Ventures Labuan Ltd, and JP Asia Prime Capital Pte Ltd. This...
View Article